Risk factors and clinical outcomes of severe community-acquired pneumonia classified by CPS-ped scale in children under 5 years

Authors

  • Patcharawadee Sridapan Pediatric department, Mukdahan hospital

Keywords:

Community-acquired pneumonia, CPS-ped, Pediatrics, Thailand

Abstract

Background: Pneumonia remains a leading cause of mortality in children under 5 years of age. Severe pneumonia impairs gas exchange, causing hypoxia, which leads to type 1 acute respiratory failure. Identifying clinical risk factors associated with disease severity could be beneficial for surveillance and treatment planning.

Objectives: To investigate the clinical risk factors associated with severe community-acquired pneumonia (CAP) and the treatment outcomes in hospitalized pediatric patients under 5 years of age.

Methods: This prognostic factor study used a retrospective design was conducted at the Department of Pediatrics, Mukdahan Hospital. Data were extracted from the inpatient medical records of pediatric patients diagnosed with CAP who were admitted between October 2023 and September 2024 and identified by the primary ICD-10 diagnostic codes (J12–J18). The Clinical Progression Scale for Pediatric Patients (CPS-ped) was used to classify severity: The severe group was defined as CPS-ped ≥ 4, and the non-severe group as CPS-ped < 4. Factors between the two groups were compared using the exact probability test. Risk factors were analyzed using multivariable logistic regression and reported as adjusted odds ratios (aOR).

Results: Of the 236 medical records reviewed, 50.0% were female, with a mean age of 27.3±15.7 months. Sixty-seven patients (28.4%) were classified as having severe pneumonia. The identified risk factors for severe pneumonia included age under 18 months (aOR 3.04, 95% CI 1.22–7.56; p value 0.017), respiratory rate exceeding age-adjusted range (aOR 8.79, 95% CI 3.21–24.05; p value < 0.001), abnormal lung sounds (aOR 4.30, 95% CI 1.54–12.02; p value < 0.001), use of accessory muscles for breathing (aOR 7.55, 95% CI 2.61–21.88; p-value < 0.001), and oxygen saturation below 95% (aOR 4.45, 95% CI 1.76–11.25; p value 0.002). Regarding treatment outcomes, the severe pneumonia group had a mean length of hospital stay of 5.1±3.0 days, with 2 deaths (3.0%). In contrast, the non-severe group had a mean length of stay of 3.4±1.8 days, with no mortalities.

Conclusions: Risk factors for severe CAP in children under 5 years old included age under 18 months, respiratory rate exceeding age-adjusted range, abnormal lung sounds, use of accessory muscles for breathing, and oxygen saturation below 95%. The mortality rate in the severe group was 3.0%. These clinical indicators might assist physicians in screening patients who required respiratory support.

Downloads

Download data is not yet available.

References

World Health Organization. Pneumonia in children [internet]. 2022 [cited 30 Jun 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/pneumonia

ระบบรายงานมาตรฐาน (HDC) กระทรวงสาธารณสุข. สถานการณ์โรคปอดอักเสบในเด็กอายุตำกว่า 5 ปี [อินเทอร์เน็ต]. 2568 [เข้าถึงเมื่อ 26 พ.ค. 2569]. เข้าถึงได้จาก: https://hdc.moph.go.th/center/public/standard-report-detail/7e5ba3f0ff6590f168f967a3f355914a?subcatalogId=3dc2d92087cdc5b585eb8c0904691399

World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: Evidence summaries [internet]. 2014 [cited 8 Nov 2024]. Available from: https://www.who.int/publications/i/item/9789241507813

Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious disease society and the infectious diseases society of America. Clin infect dis. 2011;53:e25-76

Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011. Thorax. 2011;66:ii1-23.

สมาคมโรคระบบหายใจและเวชบำบัดวิกฤตในเด็ก ราชวิทยาลัยกุมารแพทย์แห่งประเทศไทย. แนวทางการดูแลรักษาโรคติดเชื้อเฉียบพลันระบบหายใจในเด็ก พ.ศ. 2562. นนทบุรี: บียอนด์เอ็นเทอร์ไพรซ์; 2662.

The Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: The PERCH multi-country case-control study. Lancet. 2019;394:757-79.

Katz SE, Williams DJ. Pediatric community-acquired pneumonia in the United States changing epidemiology, diagnostic and therapeutic challenges, and area for future research. Infect Dis Clin N Am. 2018;32:47–63.

Meyer Sateur PM. Childhood community-acquired pneumonia. Eur J Pediatr 2024;183:1129-36.

Long ME, Mallampalli RK, Horowitz JC. Pathogenesis of pneumonia and acute lung injury. Clin Sci. 2022;136:747–69.

Emeriaud G, Lopez-Fernandez YM, Iyer NP, Bembea MM, Agulnik A, Barbaro R, et al. Executive summary of the second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PALICC-2). Pediatr Crit Care Med. 2023;24:143-67.

Leland SB, Staffa SJ, Newhams MM, Khemani KG, Marshall JC, Young CC, et al. The modified clinical progression scale for pediatric patients: evaluation as a severity metric and outcome measure in severe acute viral respiratory illness. Pediatr Crit Care Med. 2023;24:998–1009.

Wong JJM, Abbas O, Wang JQY, Xu W, Dang H, Phan PH, et al. Severe pneumonia in PICU admissions: The pediatric acute and critical care medicine Asian network (PACCMAN) observational cohort study, 2020-2022. Pediatr Crit Care Med. 2024;25:1035-44.

ศุภรัตน์ พรหมสาลี. ปัจจัยที่เกี่ยวข้องกับการเสียชีวิตในผู้ป่วยเด็กโรคปอดอักเสบที่มีภาวะหายใจล้มเหลวโรงพยาบาลปัตตานี. วารสารกุมารเวชศาสตร์ 2568; 64:128-41.

Martin H, Falconer J, Addo-Yobo E, Aneja S, Arroyo LM, Asghar R, et al. Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: methodology and application. J Glob Health. 2022;12:04075.

Dean P, Florin TA. Factors associated with pneumonia severity in children: A systematic review. J Pediatric Infect Dis Soc. 2018;7:323-34.

Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192-7.

กองโภชนาการ กรมอนามัย กระทรวงสาธารณสุข. เกณฑ์อ้างอิง น้ำหนัก ส่วนสูง และเครื่องชี้วัดภาวะโภชนาการของประชาชนไทยอายุ 1 วัน-19 ปี [อินเทอร์เน็ต]. 2543 [เข้าถึงเมื่อ 1 ต.ค. 2567]. เข้าถึงได้จาก: https://nutition2.anamai.moph.go.th

World Health Organization Pneumonia Vaccine Trial Investigators’ Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children [internet]. 2001[cited 26 May 2026]. Available from: https://iris.who.int/server/api/core/bitstreams/cec6bff5-129e-4925-a651-ab990cb289be/content

Rifai M, Bergounioux J, Sleiman N, Ismail J, Zini J. Infectious acute respiratory failure in patients under 5 years of age: A retrospective cohort study. BMJ Paediatrics Open. 2024;8:e002614.

Panetti B, Bucci I, Di Ludovico A, Pellegrino GM, Di Filippo P, Di Pillo S, et al. Acute respiratory failure in children: A clinical update on diagnosis. Children. 2024;11:1232.

Downloads

Published

2026-06-30

How to Cite

Sridapan, P. (2026). Risk factors and clinical outcomes of severe community-acquired pneumonia classified by CPS-ped scale in children under 5 years. Thai Journal of Pediatrics, 65(2), 137–153. retrieved from https://he04.tci-thaijo.org/index.php/TJP/article/view/4415

Issue

Section

Original Articles